Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice.
Dan WangJia LiChun-Qing SongKaren TranHaiwei MouPei-Hsuan WuPhillip W L TaiCraig A MendoncaLingzhi RenBlake Y WangQin SuDominic J GesslerPhillip D ZamoreWen XueGuangping GaoPublished in: Nature biotechnology (2018)
We report a genome-editing strategy to correct compound heterozygous mutations, a common genotype in patients with recessive genetic disorders. Adeno-associated viral vector delivery of Cas9 and guide RNA induces allelic exchange and rescues the disease phenotype in mouse models of hereditary tyrosinemia type I and mucopolysaccharidosis type I. This approach recombines non-mutated genetic information present in two heterozygous alleles into one functional allele without using donor DNA templates.
Keyphrases
- genome editing
- crispr cas
- early onset
- mouse model
- intellectual disability
- genome wide
- copy number
- muscular dystrophy
- sars cov
- high fat diet induced
- cell free
- wild type
- health information
- replacement therapy
- nucleic acid
- type diabetes
- dna methylation
- skeletal muscle
- adipose tissue
- gene expression
- insulin resistance
- social media
- gene therapy
- metabolic syndrome